Zydus Lifesciences Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
5,305.20
6,270.70
5,690.20
4,542.90
4,422.80
Other Income Qtr Cr68.2063.20156.4037.7054.00
Operating Revenues Qtr5,237.006,207.505,533.804,505.204,368.80

*All values are in Cr.

Operating Expenses Qtr
3,775.60
4,123.50
3,903.30
3,402.80
3,222.70
Operating Profit Qtr
1,461.40
2,084.00
1,630.50
1,102.40
1,146.10
EBIDT Qtr Cr
1,529.90
2,147.20
1,790.10
1,161.90
1,199.10
Depreciation Qtr
233.60
215.30
205.30
194.80
184.20
Net Profit Qtr
920.20
1,482.50
1,246.10
789.60
800.70
Basic EPS Qtr
9.06
14.11
11.69
7.80
7.91
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -